what percentage of people get nausea from semaglutide Side Effects: to Expect in the First Weeks Semaglutide Nausea: Timeline and Relief

However, in a study by Bezin and colleagues (2023), the use of GLP-1 RA for 1-3 years was associated with an increased risk of thyroid cancer and medullary thyroid cancer

The antioxidant properties of carotenoids have not been studied enough

Key Takeaways Tirzepatide activates two incretin hormone pathways (GLP-1 and GIP)

Compounded GLP-1s Compounded semaglutide and tirzepatide are not FDA-approved nor tested versions of these medications and do not have the same safety nor efficacy data behind them

Both are building redundancy into their supply chains to prevent bottlenecks like those that plagued early launches

The goal is to build habits they can sustain long term